🇺🇸 FDA
Pipeline program

Measles-Rubella combined vaccine(MR)

201518

Approved mab completed

Quick answer

Measles-Rubella combined vaccine(MR) for Measles is a Approved program (mab) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Measles
Phase
Approved
Modality
mab
Status
completed

Clinical trials